 MENLO PARK, Calif.--BUSINESS WIRE--Personalis, Inc. Nasdaq: PSNL, a leader in advanced genomics for population sequencing and cancer, today announced the pricing of its previously announced underwritten public offering of 3,950,000 shares of its common stock at a price to the public of 38.00 per share. Gross proceeds to Personalis from the offering are expected to be 150.1 million, before deducting underwriting discounts and commissions and estimated offering expenses. In addition, the un 